Category: Blood Diseases
Global Blood Diseases
-
Global Plasma Fractionation Market Size study & Forecast, by Product ( Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others), by Method (Centrifugation, Depth Filtration, Chromatography, Others)by Application (Neurology, Hematology, Oncology, Immunology, Pulmonology, Others), by End User(Hospitals & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030
... & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030 Global Plasma Fractionation Market is valued approximately USD 30.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% ... Read More
-
Global Hemophilia Market - 2023-2030
... expected to exhibit a CAGR of 5.9% during the forecast period 2023-2030. A spectrum of conditions impacting the body's blood clotting function is comprehended as bleeding disorders. Heeding an injury, multiple disorders can induce extreme ... Read More
-
Global Chemotherapy-Induced Anemia Market - 2023-2030
... chemotherapy-induced anemia market is expected to exhibit a cagr of 7.2% during the forecast period (2023-2030). Anemia is a condition in which the body's status of red blood cells goes below normal. When the body ... Read More
-
Global Anemia Gene Detection Kits Market Growth 2023-2029
... to grow at a CAGR of 4.8% from 2023 to 2029. United States market for Anemia Gene Detection Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Hemophilia Treatment Drugs Market Research Report 2023(Status and Outlook)
... Treatment Drugs Market Size was estimated at USD 10830.00 million in 2022 and is projected to reach USD 13778.78 million by 2029, exhibiting a CAGR of 3.50% during the forecast period. Bosson Research’s latest report ... Read More
-
Iron Deficiency Anemia (IDA) Therapy Market Forecasts to 2028 – Global Analysis By Therapy (Parenteral Iron Therapy, Oral Iron Therapy, Red Blood Cell Transfusion Therapy and Other Therapies), Therapy Area (Congestive Heart Failure (CHF), Renal, Obstetrics & Gynaecology, Oncology, Inflammatory Bowel Disease and Other Therapy Areas), Age, End User and By Geography
... Obstetrics & Gynaecology, Oncology, Inflammatory Bowel Disease and Other Therapy Areas), Age, End User and By Geography According to Stratistics MRC, the Global Iron Deficiency Anemia (IDA) Therapy Market is accounted for $1.87 billion in ... Read More
-
Global Thalassemia Market Size study & Forecast, by Therapeutic Class (Iron Chelating Drugs), by Pipeline (Gene Therapy) and Regional Analysis, 2022-2029
... to grow with a healthy growth rate of more than 5% over the forecast period 2022-2029. According to Centers for Disease Control and Prevention - Thalassemia can be defined as an inherited blood disorder caused ... Read More
-
Bleeding Disorders Market By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Treatment Type (Factor Replacement Therapy, Drug Therapy), By Distribution Channel (Hospital Pharmacies, Drug stores and retail pharmacies, Online pharmacies): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Opportunity Analysis and Industry Forecast, 2023-2032 The bleeding disorders market was valued at $13,789.66 million in 2022 and is estimated to reach $25,974.82 million by 2032, exhibiting a CAGR of 6.6% from 2023 to 2032. ... Read More
-
Global Anemia in Pregnancy Market Growth 2023-2029
... CAGR of % from 2023 to 2029. United States market for Anemia in Pregnancy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
... and End User (Hospitals, Clinics, and Others) The blood plasma derivatives market is expected to reach US$ 51,119.24 million by 2028 from US$ 29.886.12 million in 2022; it is estimated to record a CAGR of ... Read More
-
Global Haemophilia Drug Market Growth (Status and Outlook) 2023-2029
... comprehensive analysis by region and market sector of projected Haemophilia Drug sales for 2023 through 2029. With Haemophilia Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in ... Read More
-
Global Anemia Treatment Market Growth (Status and Outlook) 2023-2029
... carry oxygen.[5] When anemia comes on slowly, the symptoms are often vague and may include feeling tired, weakness, shortness of breath or a poor ability to exercise. LPI (LP Information)' newest research report, the “Anemia ... Read More
-
Global Sickle-cell Anemia Therapeutics Market Growth (Status and Outlook) 2023-2029
... the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). LPI (LP Information)' newest research report, the ... Read More
-
Global Renal Anemia Therapeutics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Renal Anemia Therapeutics sales for 2023 through 2029. With Renal Anemia Therapeutics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Global Bleeding Disorders Treatment Market Size study & Forecast, by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), by Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others) and Regional Analysis, 2022-2029
... and Regional Analysis, 2022-2029 Global Bleeding Disorders Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
-
Global Hemophilia Drugs Market Growth 2023-2029
... factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II study of hemophilia medicine ‘Emicizumab’ by Roche has demonstrated promising results regarding ... Read More
-
Global Anemia and Vitamin Test Market Growth (Status and Outlook) 2023-2029
... important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or low level of haemoglobin that ... Read More
-
Sickle Cell Anemia Testing & Screening Market Intelligence Report - Global Forecast 2023-2030
... in 2022, at a CAGR 13.49% during the forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support ... Read More
-
Global PEGylated Proteins Market Size study & Forecast, by Protein Type (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, Others), by Product & Services (Consumables, Services), by Application (Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029
... disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029 Global PEGylated Proteins Market is valued at approximately USD 1.14 billion in 2021 and is anticipated ... Read More
-
Global Rare Haematology Market - 2023-2030
... CAGR of XX% during the forecast period (2023-2030). A small number of individuals have rare blood diseases. They can impact platelets, red blood cells, or white blood cells, which makes it challenging to transfer oxygen ... Read More
-
Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2023-2029
... a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. ... Read More
-
Bleeding Disorders Treatment Global Market Report 2022: Ukraine-Russia War Impact
... information they need to assess the global bleeding disorders treatment market. This report focuses on bleeding disorders treatment market which is experiencing strong growth. The report gives a guide to the bleeding disorders treatment market ... Read More
-
Global Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Regional Outlook and Forecast, 2022 - 2028
... The Global Hemoglobinopathies Market size is expected to reach $6.0 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast period. In its stable state, normal human hemoglobin’s are tetrameric protein ... Read More
-
Global Aplastic Anemia Market - 2022-2029
... during the forecast period (2022-2029). Aplastic anemia is a condition that happens when the body stops generating sufficient new blood cells. The condition leaves a person tired and more prone to uncontrolled bleeding and infections. ... Read More
-
Thalassemia Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Iron Chelating Drugs, Blood Transfusions, Folic Acid Supplements, Gene Therapy, Others); By End-Use; By Disease Type; By Region; Segment Forecast, 2022 - 2030
... global thalassemia market size is expected to reach USD 1,492.9 billion by 2030, according to a new study by Polaris Market Research. The report “Thalassemia Market Share, Size, Trends, Industry Analysis Report, By Treatment Type ... Read More
Research Assistance
